---
$id: https://graph.org.ai/products/commodity/51313511
$type: Product
source: UNSPSC
code: "51313511"
title: "Trenizine"
class: "51313500"
classTitle: "Antihistamine or H1 blockers, synthesized"
family: "51310000"
familyTitle: "Antihistamines or H1 blockers"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Trenizine

**UNSPSC Code**: 51313511
**Class**: [Antihistamine or H1 blockers, synthesized](Antihistamine or H1 blockers, synthesized.mdx)
**Family**: [Antihistamines or H1 blockers](../Antihistamines or H1 blockers.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1WPQ720NCK. European Medicines Agency schedules Trenizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11234MIG. Trenizine generally arises in the molecular formula C31H40N2O. The term TRENIZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, no. 6, 1983, list 23.) TRENIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trenizine under HS 29335995 and SITC 51576. As of Q4 2014, TRENIZINE remains the US FDA Preferred Term for this commodity. Trenizine bears US NLM identifiers UMLS ID C1883389 and NCI Concept Code C66622. SMILES: OC(CCCN1CCN(CC1)C(C1CCCCC1)C1CCCCC1)C1CCC(C(C)(C)C)CC1.

